(b)(4).Device evaluation by manufacturer: on 04-apr-2018, a field service engineer (fse) was dispatched to the customer's facility to address the reported event.Fse verified the 711 line valve error through the instrument's error log.Fse replaced the asm pcb board and verified proper operation.Fse ran precision, quality controls (qc), and patient samples.All results were with acceptable range and the error cleared.The g8 instrument was performing as intended.No further action was required from field service.A (b)(4) complaint history review and service history review for serial number (b)(4) from (b)(6) 2017 through the awareness date (b)(6) 2018 for similar complaints was performed.There were two (2x) other similar complaints identified during the searched period.The g8 variant analysis mode operator's manual under chapter 6, troubleshooting, states the following: the 6.3 error messages: when consulting with technical support about a problem, please note the error message and error number.In addition, if you follow the suggested solutions in this section and are still unable to resolve the error, or if you encounter an error message that is not noted, contact technical support.General error messages: with these errors, the assay stops and the analyzer immediately enters stand-by state.The 711 line valve error: explanation: operation error in switching valve (as valve) countermeasure: inspect valve on line.Execute smp.Reset.The most probable cause of the reported event was due to defective asm board.
|
On (b)(6) 2018, a customer reported getting message 711 line valve while running quality controls (qc) on the g8 instrument.Customer stated the error persists despite rebooting.Field service engineer (fse) was dispatched to address the reported event, which resulted in delay in reporting of patient results for hemoglobin a1c (hba1c).There was no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
|